Efficacy of Alpha Lipoic Acid Combined With Myo-Inositol in Non-Diabetic PCOS Patients
ConditionPoly Cystic Ovary Syndrome
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexFemale
Age21-40
SponsorBeni-Suef University
About this trial
This study evaluates the efficacy of alpha-lipoic acid combined with myo-inositol, with or without metformin, in improving menstrual regularity and ovulation in non-diabetic women with polycystic ovary syndrome (PCOS). The study also assesses metabolic, hormonal, and clinical outcomes.
Eligibility criteria
Qualifiers
Women aged 21 to 40 years
Diagnosed with polycystic ovary syndrome (PCOS) according to Rotterdam criteria
Not currently pregnant or lactating
No hormonal therapy within the last 3 months
Disqualifiers
- History of diabetes mellitus, hypertension, or thyroid disorders
History of cardiovascular, renal, or hepatic disease
Use of hormonal contraceptives or insulin sensitizers within the last 3 months
Known hypersensitivity or allergy to study medications (myo-inositol, alpha-lipoic acid, or metformin)
Trial design
Treatments tested in this trial
- Myo-inositol
- Folic Acid
- Alpha Lipoic Acid
- Metfomin
Treatment groups
180 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov